[
  {
    "ts": null,
    "headline": "Viatris Inc. stock falls Tuesday, underperforms market",
    "summary": "Viatris Inc. stock falls Tuesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=201232a32ca7ffd7e6d936f3e7ffcff5e64fdf09fc2fea848bf5d96661f9af8a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752599820,
      "headline": "Viatris Inc. stock falls Tuesday, underperforms market",
      "id": 135992025,
      "image": "",
      "related": "VTRS",
      "source": "MarketWatch",
      "summary": "Viatris Inc. stock falls Tuesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=201232a32ca7ffd7e6d936f3e7ffcff5e64fdf09fc2fea848bf5d96661f9af8a"
    }
  },
  {
    "ts": null,
    "headline": "XPH: Healthcare Dashboard For July",
    "summary": "XPH ETF offers equal-weighted exposure to pharmaceutical companies, with lackluster results for a decade. Click here to find out why XPH stock is a Hold.",
    "url": "https://finnhub.io/api/news?id=f06d8fa42a12451bc189fb589853168778c65a1452470f7473adbf64804e67f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752599588,
      "headline": "XPH: Healthcare Dashboard For July",
      "id": 135956660,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1557045133/image_1557045133.jpg?io=getty-c-w1536",
      "related": "VTRS",
      "source": "SeekingAlpha",
      "summary": "XPH ETF offers equal-weighted exposure to pharmaceutical companies, with lackluster results for a decade. Click here to find out why XPH stock is a Hold.",
      "url": "https://finnhub.io/api/news?id=f06d8fa42a12451bc189fb589853168778c65a1452470f7473adbf64804e67f9"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma",
    "summary": "Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval from China’s National Medical Products Administration/NMPA for Yupelri (revefenacin) inhalation solution for the maintenance treatment of chronic obstructive pulmonary disease/COPD. Yupelri is the first ever once-daily nebulized long-acting muscarinic antagonist/LAMA approved in China for […]",
    "url": "https://finnhub.io/api/news?id=7a1f1efbca5277d9103f75304ed244fc251355b7148ae75a1820b9ac3b063ff2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752584350,
      "headline": "Viatris Gains China Approval for COPD Drug Yupelri, Triggers $7.5M Payment to Theravance BioPharma",
      "id": 135962048,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval from China’s National Medical Products Administration/NMPA for Yupelri (revefenacin) inhalation solution for the maintenance treatment of chronic obstructive pulmonary disease/COPD. Yupelri is the first ever once-daily nebulized long-acting muscarinic antagonist/LAMA approved in China for […]",
      "url": "https://finnhub.io/api/news?id=7a1f1efbca5277d9103f75304ed244fc251355b7148ae75a1820b9ac3b063ff2"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Certified as a Great Place to Work® in Canada",
    "summary": "Viatris Inc. (Nasdaq: VTRS) has been certified as a Great Place to Work® in Canada. This recognition highlights Viatris' commitment to fostering a culture where colleagues are enthusiastic about the work they do and feel valued, engaged and motivated.",
    "url": "https://finnhub.io/api/news?id=c460feb53467502be1ab26674b1069268901673fce1da86765110568c2c06aab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752577140,
      "headline": "Viatris Certified as a Great Place to Work® in Canada",
      "id": 135962050,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (Nasdaq: VTRS) has been certified as a Great Place to Work® in Canada. This recognition highlights Viatris' commitment to fostering a culture where colleagues are enthusiastic about the work they do and feel valued, engaged and motivated.",
      "url": "https://finnhub.io/api/news?id=c460feb53467502be1ab26674b1069268901673fce1da86765110568c2c06aab"
    }
  }
]